Tzemin Sung
About Tzemin Sung
Tzemin Sung is the Senior Director of DS Manufacturing at BeiGene and Associate Director of Drug Substance Technical Support at Samsung Biologics, with over 20 years of experience in the biopharmaceutical industry.
Current Roles at BeiGene and Samsung Biologics
Tzemin Sung is currently serving as the Senior Director of Drug Substance (DS) Manufacturing at BeiGene. In this role, he oversees the manufacturing processes related to drug substances, ensuring high quality and efficiency. Concurrently, he holds the position of Associate Director of Drug Substance Technical Support at Samsung Biologics, where he provides critical technical support to drug substance manufacturing operations.
Professional Background in Biopharmaceuticals
Tzemin Sung has amassed over 20 years of experience in the biopharmaceutical industry, specializing in downstream manufacturing processes. His career includes notable roles such as Downstream Manufacturing Technology at Bristol-Myers Squibb in New York from 2003 to 2015, Shift Supervisor at Biogen from 2001 to 2003, and Downstream Process Operator at Regeneron Pharmaceuticals, Inc. from 1998 to 2001. His extensive career in varied roles has equipped him with a comprehensive understanding of the biopharmaceutical manufacturing landscape.
Educational Background
Tzemin Sung completed his higher education at prestigious institutions. He earned a Master of Science degree from Syracuse University between 2008 and 2010. Prior to that, he obtained a Bachelor of Arts degree from Le Moyne College, attending from 1995 to 1997. This strong educational foundation has been instrumental in his career, providing him with the theoretical underpinning necessary for his extensive practical work in the biopharmaceutical industry.
Experience with Leading Biopharmaceutical Companies
Throughout his career, Tzemin Sung has worked with both small and large biopharmaceutical companies, contributing to his robust expertise in drug substance manufacturing. His past roles include 12 years at Bristol-Myers Squibb focusing on downstream manufacturing technology and earlier positions at Biogen and Regeneron Pharmaceuticals, Inc. These experiences have enriched his understanding of the complexities of drug substance manufacturing and prepared him for leadership roles in his current positions at BeiGene and Samsung Biologics.
Leadership in Technical Support and Manufacturing Technology
Tzemin Sung has consistently held leadership roles throughout his career. His expertise in technical support and manufacturing technology has enabled him to lead various teams effectively. At BeiGene, as Senior Director of DS Manufacturing, and at Samsung Biologics, as Associate Director of Drug Substance Technical Support, he leverages his extensive knowledge and experience to guide manufacturing operations and technical support functions, driving efficiency and quality in drug substance production.